US 10301317
Inhibitors of ERK and methods of use
granted A61KA61K31/4439A61K31/4745
Quick answer
US patent 10301317 (Inhibitors of ERK and methods of use) held by Kura Oncology, Inc. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K31/4439, A61K31/4745, A61K31/513, A61K31/5377